Data as of 3:20pm ET
| -1.06 / -3.94%|
The 9 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 34.79, with a high estimate of 66.43 and a low estimate of 17.70. The median estimate represents a +34.57% increase from the last price of 25.85.
The current consensus among 8 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.